1. Home
  2. ABCL vs CRESY Comparison

ABCL vs CRESY Comparison

Compare ABCL & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • CRESY
  • Stock Information
  • Founded
  • ABCL 2012
  • CRESY 1936
  • Country
  • ABCL Canada
  • CRESY Argentina
  • Employees
  • ABCL N/A
  • CRESY N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • CRESY Real Estate
  • Sector
  • ABCL Health Care
  • CRESY Finance
  • Exchange
  • ABCL Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • ABCL 895.0M
  • CRESY 815.5M
  • IPO Year
  • ABCL 2020
  • CRESY 1997
  • Fundamental
  • Price
  • ABCL $2.69
  • CRESY $12.75
  • Analyst Decision
  • ABCL Buy
  • CRESY
  • Analyst Count
  • ABCL 3
  • CRESY 0
  • Target Price
  • ABCL $8.50
  • CRESY N/A
  • AVG Volume (30 Days)
  • ABCL 2.4M
  • CRESY 340.2K
  • Earning Date
  • ABCL 11-04-2024
  • CRESY 02-07-2025
  • Dividend Yield
  • ABCL N/A
  • CRESY 7.68%
  • EPS Growth
  • ABCL N/A
  • CRESY N/A
  • EPS
  • ABCL N/A
  • CRESY N/A
  • Revenue
  • ABCL $32,962,000.00
  • CRESY $751,941,316.00
  • Revenue This Year
  • ABCL N/A
  • CRESY N/A
  • Revenue Next Year
  • ABCL $36.56
  • CRESY N/A
  • P/E Ratio
  • ABCL N/A
  • CRESY N/A
  • Revenue Growth
  • ABCL N/A
  • CRESY N/A
  • 52 Week Low
  • ABCL $2.34
  • CRESY $6.56
  • 52 Week High
  • ABCL $6.06
  • CRESY $14.23
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 42.74
  • CRESY 53.57
  • Support Level
  • ABCL $2.76
  • CRESY $13.12
  • Resistance Level
  • ABCL $3.05
  • CRESY $14.11
  • Average True Range (ATR)
  • ABCL 0.17
  • CRESY 0.70
  • MACD
  • ABCL -0.03
  • CRESY -0.11
  • Stochastic Oscillator
  • ABCL 6.98
  • CRESY 28.50

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: